DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l65wld/biomarkers_in) has announced the addition of the "Biomarkers in Amyotrophic Lateral Sclerosis - Overview " report to their offering.
Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders, specifically Amyotrophic Lateral Sclerosis (ALS). This report covers extensive background information, highlights market growth and outlook, and features clinical trial and pipeline information.
Biomarkers in Amyotrophic Lateral Sclerosis is focused on the biomarker identification and development in patients with Amyotrophic Lateral Sclerosis (ALS). This report focuses on the ALS space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the use of biomarkers for Amyotrophic Lateral Sclerosis, Biomarkers in Amyotrophic Lateral Sclerosis captures market growth of biomarkers, advantages, disadvantages, and validation techniques.
Experts interviewed in this report include:
Dr. Merit Ester Cudkowicz, Chief of Neurology at Massachusetts General Hospital
Dr. Andreas Jeromin, CSO and President of Atlantic Biomarkers
Also available in this report is extensive survey data exclusively conducted for this report. Illustrated by 30 figures captured by an in-depth analysis, this section features insight into targets under investigation, challenges, advantages, and desired features of future diagnostic applications.
Finally, the report concludes with clinical trial and pipeline data featuring targets and products from over 30 companies working in Amyotrophic Lateral Sclerosis.
Key Topics Covered:
Chapter 1: The Focus Of This Report
Chapter 2: Biomarkers And Their Clinical Utility
Chapter 3: Biomarkers In Neurodegenerative Disorders
Chapter 4: Amyotrophic Lateral Sclerosis
Chapter 5: Biomarkers For Diagnostics
Chapter 6:Survey Results
Chapter 7: Clinical Trials And Pipeline Information For Amyotrophic Lateral Sclerosis*
For more information visit http://www.researchandmarkets.com/research/l65wld/biomarkers_in